CN104739865B - 一种制备胎盘造血干细胞制剂的方法 - Google Patents
一种制备胎盘造血干细胞制剂的方法 Download PDFInfo
- Publication number
- CN104739865B CN104739865B CN201510078363.1A CN201510078363A CN104739865B CN 104739865 B CN104739865 B CN 104739865B CN 201510078363 A CN201510078363 A CN 201510078363A CN 104739865 B CN104739865 B CN 104739865B
- Authority
- CN
- China
- Prior art keywords
- hydroxyethyl starch
- stem cell
- hematopoietic stem
- enzyme
- mixed
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 210000002662 placental hematopoietic stem cell Anatomy 0.000 title claims abstract description 41
- 238000002360 preparation method Methods 0.000 title claims abstract description 31
- 238000000034 method Methods 0.000 title claims abstract description 30
- 239000000243 solution Substances 0.000 claims abstract description 64
- 102000004190 Enzymes Human genes 0.000 claims abstract description 59
- 108090000790 Enzymes Proteins 0.000 claims abstract description 59
- 229940088598 enzyme Drugs 0.000 claims abstract description 59
- 229920001612 Hydroxyethyl starch Polymers 0.000 claims abstract description 45
- 229940050526 hydroxyethylstarch Drugs 0.000 claims abstract description 45
- 239000011550 stock solution Substances 0.000 claims abstract description 31
- 239000007788 liquid Substances 0.000 claims abstract description 29
- 239000000725 suspension Substances 0.000 claims abstract description 26
- 230000029087 digestion Effects 0.000 claims abstract description 25
- 210000005059 placental tissue Anatomy 0.000 claims abstract description 25
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 claims abstract description 22
- 229920002307 Dextran Polymers 0.000 claims abstract description 16
- 239000000463 material Substances 0.000 claims abstract description 15
- 108010003272 Hyaluronate lyase Proteins 0.000 claims abstract description 14
- 102000001974 Hyaluronidases Human genes 0.000 claims abstract description 14
- 230000002255 enzymatic effect Effects 0.000 claims abstract description 14
- 229960002773 hyaluronidase Drugs 0.000 claims abstract description 14
- 102000012422 Collagen Type I Human genes 0.000 claims abstract description 13
- 108010022452 Collagen Type I Proteins 0.000 claims abstract description 13
- 102000008100 Human Serum Albumin Human genes 0.000 claims abstract description 12
- 108091006905 Human Serum Albumin Proteins 0.000 claims abstract description 12
- 108010007093 dispase Proteins 0.000 claims abstract description 10
- 231100000732 tissue residue Toxicity 0.000 claims abstract description 10
- TWRXJAOTZQYOKJ-UHFFFAOYSA-L Magnesium chloride Chemical compound [Mg+2].[Cl-].[Cl-] TWRXJAOTZQYOKJ-UHFFFAOYSA-L 0.000 claims description 20
- WCUXLLCKKVVCTQ-UHFFFAOYSA-M Potassium chloride Chemical compound [Cl-].[K+] WCUXLLCKKVVCTQ-UHFFFAOYSA-M 0.000 claims description 20
- VMHLLURERBWHNL-UHFFFAOYSA-M Sodium acetate Chemical compound [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 claims description 10
- 229910001629 magnesium chloride Inorganic materials 0.000 claims description 10
- 239000001103 potassium chloride Substances 0.000 claims description 10
- 235000011164 potassium chloride Nutrition 0.000 claims description 10
- 239000001632 sodium acetate Substances 0.000 claims description 10
- 235000017281 sodium acetate Nutrition 0.000 claims description 10
- AEQDJSLRWYMAQI-UHFFFAOYSA-N 2,3,9,10-tetramethoxy-6,8,13,13a-tetrahydro-5H-isoquinolino[2,1-b]isoquinoline Chemical compound C1CN2CC(C(=C(OC)C=C3)OC)=C3CC2C2=C1C=C(OC)C(OC)=C2 AEQDJSLRWYMAQI-UHFFFAOYSA-N 0.000 claims description 9
- 239000000176 sodium gluconate Substances 0.000 claims description 9
- 235000012207 sodium gluconate Nutrition 0.000 claims description 9
- 229940005574 sodium gluconate Drugs 0.000 claims description 9
- 238000001914 filtration Methods 0.000 claims description 7
- 238000005119 centrifugation Methods 0.000 claims description 6
- 125000001301 ethoxy group Chemical group [H]C([H])([H])C([H])([H])O* 0.000 claims description 5
- 239000000843 powder Substances 0.000 claims description 5
- 239000013049 sediment Substances 0.000 claims description 5
- 230000003204 osmotic effect Effects 0.000 claims description 3
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 claims description 2
- 239000011734 sodium Substances 0.000 claims description 2
- 229910052708 sodium Inorganic materials 0.000 claims description 2
- 239000006285 cell suspension Substances 0.000 claims 1
- 238000005660 chlorination reaction Methods 0.000 claims 1
- 238000010792 warming Methods 0.000 abstract description 4
- 238000009168 stem cell therapy Methods 0.000 abstract description 2
- 238000009580 stem-cell therapy Methods 0.000 abstract description 2
- 239000000047 product Substances 0.000 description 25
- 210000002826 placenta Anatomy 0.000 description 22
- 210000004027 cell Anatomy 0.000 description 19
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 18
- 210000000130 stem cell Anatomy 0.000 description 17
- 239000011780 sodium chloride Substances 0.000 description 9
- 238000007710 freezing Methods 0.000 description 8
- 230000008014 freezing Effects 0.000 description 8
- 230000000052 comparative effect Effects 0.000 description 7
- 210000004700 fetal blood Anatomy 0.000 description 6
- 102100031573 Hematopoietic progenitor cell antigen CD34 Human genes 0.000 description 5
- 101000777663 Homo sapiens Hematopoietic progenitor cell antigen CD34 Proteins 0.000 description 5
- 210000004369 blood Anatomy 0.000 description 5
- 239000008280 blood Substances 0.000 description 5
- 210000003958 hematopoietic stem cell Anatomy 0.000 description 5
- 238000002347 injection Methods 0.000 description 5
- 239000007924 injection Substances 0.000 description 5
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 4
- 239000006185 dispersion Substances 0.000 description 4
- 239000003814 drug Substances 0.000 description 4
- 230000003394 haemopoietic effect Effects 0.000 description 4
- 101000738771 Homo sapiens Receptor-type tyrosine-protein phosphatase C Proteins 0.000 description 3
- NIPNSKYNPDTRPC-UHFFFAOYSA-N N-[2-oxo-2-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)ethyl]-2-[[3-(trifluoromethoxy)phenyl]methylamino]pyrimidine-5-carboxamide Chemical compound O=C(CNC(=O)C=1C=NC(=NC=1)NCC1=CC(=CC=C1)OC(F)(F)F)N1CC2=C(CC1)NN=N2 NIPNSKYNPDTRPC-UHFFFAOYSA-N 0.000 description 3
- 102100037422 Receptor-type tyrosine-protein phosphatase C Human genes 0.000 description 3
- 238000002054 transplantation Methods 0.000 description 3
- 210000001744 T-lymphocyte Anatomy 0.000 description 2
- 210000003719 b-lymphocyte Anatomy 0.000 description 2
- 230000001413 cellular effect Effects 0.000 description 2
- 238000009826 distribution Methods 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 210000003743 erythrocyte Anatomy 0.000 description 2
- 230000011132 hemopoiesis Effects 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 229910052757 nitrogen Inorganic materials 0.000 description 2
- 230000005855 radiation Effects 0.000 description 2
- 238000006467 substitution reaction Methods 0.000 description 2
- 229940124597 therapeutic agent Drugs 0.000 description 2
- YCIHPQHVWDULOY-FMZCEJRJSA-N (4s,4as,5as,6s,12ar)-4-(dimethylamino)-1,6,10,11,12a-pentahydroxy-6-methyl-3,12-dioxo-4,4a,5,5a-tetrahydrotetracene-2-carboxamide;hydrochloride Chemical compound Cl.C1=CC=C2[C@](O)(C)[C@H]3C[C@H]4[C@H](N(C)C)C(=O)C(C(N)=O)=C(O)[C@@]4(O)C(=O)C3=C(O)C2=C1O YCIHPQHVWDULOY-FMZCEJRJSA-N 0.000 description 1
- 102100031585 ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1 Human genes 0.000 description 1
- 102100024222 B-lymphocyte antigen CD19 Human genes 0.000 description 1
- 241000192700 Cyanobacteria Species 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 239000012981 Hank's balanced salt solution Substances 0.000 description 1
- 101000777636 Homo sapiens ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1 Proteins 0.000 description 1
- 101000980825 Homo sapiens B-lymphocyte antigen CD19 Proteins 0.000 description 1
- 101000934338 Homo sapiens Myeloid cell surface antigen CD33 Proteins 0.000 description 1
- 241000699660 Mus musculus Species 0.000 description 1
- 102100025243 Myeloid cell surface antigen CD33 Human genes 0.000 description 1
- 229930182555 Penicillin Natural products 0.000 description 1
- JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 description 1
- 206010060872 Transplant failure Diseases 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000000740 bleeding effect Effects 0.000 description 1
- 210000001772 blood platelet Anatomy 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 230000035606 childbirth Effects 0.000 description 1
- 210000001136 chorion Anatomy 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 238000005138 cryopreservation Methods 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000012467 final product Substances 0.000 description 1
- 238000000684 flow cytometry Methods 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 239000003292 glue Substances 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- 230000005847 immunogenicity Effects 0.000 description 1
- 230000007365 immunoregulation Effects 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- 238000009940 knitting Methods 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 210000004698 lymphocyte Anatomy 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 210000003716 mesoderm Anatomy 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 230000004899 motility Effects 0.000 description 1
- 210000003097 mucus Anatomy 0.000 description 1
- 210000000066 myeloid cell Anatomy 0.000 description 1
- 238000011580 nude mouse model Methods 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 229940049954 penicillin Drugs 0.000 description 1
- 230000010412 perfusion Effects 0.000 description 1
- 230000009984 peri-natal effect Effects 0.000 description 1
- 210000005259 peripheral blood Anatomy 0.000 description 1
- 239000011886 peripheral blood Substances 0.000 description 1
- 230000002093 peripheral effect Effects 0.000 description 1
- 230000035479 physiological effects, processes and functions Effects 0.000 description 1
- 230000001376 precipitating effect Effects 0.000 description 1
- 239000002243 precursor Substances 0.000 description 1
- 238000003908 quality control method Methods 0.000 description 1
- 230000002285 radioactive effect Effects 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 238000009738 saturating Methods 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 239000002893 slag Substances 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 210000001113 umbilicus Anatomy 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Landscapes
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Description
Claims (8)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510078363.1A CN104739865B (zh) | 2015-02-13 | 2015-02-13 | 一种制备胎盘造血干细胞制剂的方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510078363.1A CN104739865B (zh) | 2015-02-13 | 2015-02-13 | 一种制备胎盘造血干细胞制剂的方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN104739865A CN104739865A (zh) | 2015-07-01 |
CN104739865B true CN104739865B (zh) | 2018-12-18 |
Family
ID=53580489
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201510078363.1A Active CN104739865B (zh) | 2015-02-13 | 2015-02-13 | 一种制备胎盘造血干细胞制剂的方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN104739865B (zh) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105477017A (zh) * | 2015-12-03 | 2016-04-13 | 深圳爱生再生医学科技有限公司 | 治疗糖尿病足的混合干细胞制剂及其制备方法 |
CN106417253A (zh) * | 2016-09-30 | 2017-02-22 | 广州赛莱拉干细胞科技股份有限公司 | 一种骨骼肌干细胞的冻存液和冻存方法 |
CN106508892A (zh) * | 2016-11-30 | 2017-03-22 | 广州赛莱拉干细胞科技股份有限公司 | 一种脐带组织冻存液及冻存方法 |
CN107041361A (zh) * | 2017-04-20 | 2017-08-15 | 北京奥康华医学检验所有限公司 | 一种肿瘤组织的保存方法及保存试剂 |
CN107183008A (zh) * | 2017-05-27 | 2017-09-22 | 魏方萌 | 一种胎盘间充质干细胞冻存液及其冻存方法 |
CN108913661A (zh) * | 2018-06-22 | 2018-11-30 | 安徽 | 一种人体研究用造血干细胞的制备和提取方法 |
CN109370984A (zh) * | 2018-08-14 | 2019-02-22 | 上海逍鹏生物科技有限公司 | 一种原代干细胞分离液以及分离原代间充质干细胞的方法 |
CN114271263A (zh) * | 2021-12-30 | 2022-04-05 | 杭州芯递力生物科技有限公司 | 一种细胞保存液、冻存套装及细胞冻存方法 |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101990888A (zh) * | 2009-08-31 | 2011-03-30 | 深圳市北科生物科技有限公司 | 干细胞冻存液及干细胞的冻存方法 |
CN102757935A (zh) * | 2011-04-29 | 2012-10-31 | 北京汉氏联合生物技术有限公司 | 一种从胎盘绒毛膜组织中提取造血干细胞的方法及造血干细胞库的构建方法 |
CN103563888A (zh) * | 2013-10-31 | 2014-02-12 | 北京永泰免疫应用科技有限公司 | 细胞冻存液 |
CN103789262A (zh) * | 2014-02-17 | 2014-05-14 | 宁波普莱森特生物科技有限公司 | 一种临床应用级胎盘造血干细胞的制备方法及保存方法 |
CN104026118A (zh) * | 2013-11-13 | 2014-09-10 | 杭州易文赛生物技术有限公司 | 一种免疫细胞冻存液、其制备方法及应用 |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20070122392A1 (en) * | 2005-06-22 | 2007-05-31 | Sharon Gerecht-Nir | Propagation of undifferentiated embryonic stem cells in hyaluronic acid hydrogel |
-
2015
- 2015-02-13 CN CN201510078363.1A patent/CN104739865B/zh active Active
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101990888A (zh) * | 2009-08-31 | 2011-03-30 | 深圳市北科生物科技有限公司 | 干细胞冻存液及干细胞的冻存方法 |
CN102757935A (zh) * | 2011-04-29 | 2012-10-31 | 北京汉氏联合生物技术有限公司 | 一种从胎盘绒毛膜组织中提取造血干细胞的方法及造血干细胞库的构建方法 |
CN103563888A (zh) * | 2013-10-31 | 2014-02-12 | 北京永泰免疫应用科技有限公司 | 细胞冻存液 |
CN104026118A (zh) * | 2013-11-13 | 2014-09-10 | 杭州易文赛生物技术有限公司 | 一种免疫细胞冻存液、其制备方法及应用 |
CN103789262A (zh) * | 2014-02-17 | 2014-05-14 | 宁波普莱森特生物科技有限公司 | 一种临床应用级胎盘造血干细胞的制备方法及保存方法 |
Also Published As
Publication number | Publication date |
---|---|
CN104739865A (zh) | 2015-07-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN104739865B (zh) | 一种制备胎盘造血干细胞制剂的方法 | |
CN110050782B (zh) | 一种干细胞冻存液及其制备方法和冻存方法 | |
CA2214280C (en) | Cryopreservation solution | |
EP2210608A1 (en) | Pharmaceutical composition containing human mesenchymal stem cell | |
JP2016216470A (ja) | 早産の合併症の治療 | |
CA3046566A1 (en) | Post-partum mammalian placental stem cells for use in the treatment of neurological or renal diseases and disorders | |
JP2020191861A (ja) | 臍帯間葉系幹細胞MSCs及びその培養法と応用 | |
CN107912421A (zh) | 一种用于骨髓间充质干细胞移植的干细胞保存液 | |
CN109892319B (zh) | 一种用于猪胰岛细胞的冻存复苏方法及冻存液和复苏液 | |
CN110037010B (zh) | 一种温敏凝胶制剂及低温长期保存胰岛细胞的方法 | |
Česen Mazič et al. | Treatment of severe steroid-refractory acute-graft-vs.-host disease with mesenchymal stem cells–single center experience | |
CN107912424A (zh) | 一种犬间充质干细胞专用常温保存液及应用 | |
CN112167240A (zh) | 临床级细胞冷藏保存液及其制备方法和应用 | |
KR20080027295A (ko) | 혈장-제거되고, 적혈구-비제거된 제대혈 조성물 및 사용방법 | |
JP2012514002A (ja) | 移植用膵臓組織及び膵島細胞保存のための器具及び方法 | |
CN105211054B (zh) | 一种含重组人prdx4蛋白的人精液冷冻保护剂 | |
WO2021129560A1 (zh) | 脂肪组织冻存保护剂 | |
Khodabux et al. | The use of cord blood for transfusion purposes: current status | |
Valeri et al. | Recent advances in freeze-preservation of red blood cells | |
CN114190367B (zh) | 冻存液及其制备方法与在免疫细胞的应用 | |
CN111449053A (zh) | 一种免疫细胞储存液及其制备与应用方法 | |
CN112956473B (zh) | 一种人造透明带及制备方法 | |
CN111374123B (zh) | 中性氨基酸作为细胞低温保护剂的使用方法及其应用 | |
Heazlewood et al. | Exploring the human term placenta as a novel source for stem cells and their application in the clinic | |
CA2668608A1 (en) | Methods for using aldhbr cells to supplement stem cell transplantation |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
CP02 | Change in the address of a patent holder |
Address after: 311121 room 402, building 3, No. 1500, Wenyi West Road, Cangqian street, Yuhang District, Hangzhou City, Zhejiang Province Patentee after: HANGZHOU S-EVANS BIOSCIENCES, Ltd. Address before: 311121 No. 25, Fengling Road, Wuchang Street, Yuhang District, Hangzhou City, Zhejiang Province Patentee before: HANGZHOU S-EVANS BIOSCIENCES, Ltd. |
|
CP02 | Change in the address of a patent holder | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: A method for preparing placental hematopoietic stem cell preparations Granted publication date: 20181218 Pledgee: Zhejiang Hangzhou Yuhang Rural Commercial Bank Co.,Ltd. Science and Technology City Branch Pledgor: HANGZHOU S-EVANS BIOSCIENCES, Ltd. Registration number: Y2024980003656 |
|
PE01 | Entry into force of the registration of the contract for pledge of patent right |